Grace Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Grace Therapeutics, Inc.
CIK #0001444192
EDGAR Form CIK 2011 - 2025
10-K [0001444192]
10-Q [0001444192]
3 [0001444192]
4 [0001444192]
6-K [0001444192]
8-K [0001444192]
D [0001444192]
SC 13D [0001444192]
SC 13G [0001444192]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Grace Therapeutics Inc [2025-05-15]
Adar1 Capital Management LLC Acasti Pharma Inc [2024-07-10]
Hirschman Orin Acasti Pharma Inc [2024-04-09]
Bank of America Corp /DE/ Acasti Pharma Inc [2024-02-13]
Peizer Terren S Acasti Pharma Inc [2019-07-19]
Haywood George Weaver Acasti Pharma Inc [2017-03-22]
Neptune Technologies & Bioressources Inc Acasti Pharma Inc [2013-12-18]
Form 3/4/5 Subject 2011 - 2025
Davis A Brian
Grace Therapeutics, Inc.
Neugeboren Edward
Kottayil George
Kavuru Vimal
DelAversano Robert J
Macdonald R. Loch
Kumar Amresh
D'Andrea Carrie
Kohli Prashant
View All
Terms | Privacy | Guide
tony@aum13f.com